Product Information

AMLODIPINE-VALSARTAN 10-160 MG is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.3592 per EA under NDC 62332020690. Its NADAC has been published 473 times since Aug 2, 2017.

FDA first approved this application on Apr 3, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

AMLODIPINE-VALSARTAN 10-160 MG

Amlodipine and Valsartan
$0.3592per EA

Strength

10; 160 mg/1; mg/1

NDC

62332020690

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA202713

FDA Approved

4/3/2015

TE Code

AB

On Market Since

12/1/2016

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker
Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A Inhibitors
Dihydropyridine Calcium Channel Blocker
Dihydropyridines

Price Statistics

The NADAC for AMLODIPINE-VALSARTAN 10-160 MG has been published 473 times since Aug 2, 2017, and over the history we have for it it has declined 26.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3592 per EA
All-time high$0.6405 (Aug 11, 2021)
All-time low$0.3145 (May 22, 2024)
52-week high$0.5174
52-week low$0.3592
Median price$0.5068
Average price$0.4952
Largest weekly change+63.9% (Jun 19, 2024)
Weeks tracked473
Tracking sinceAug 2, 2017

Price History

1W

-6.7%

1M

-6.7%

3M

-23.3%

6M

-26.8%

1Y

-30.6%

3Y

-33.8%

5Y

-37.9%

All

-26.0%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of AMLODIPINE-VALSARTAN 10-160 MG?

The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-VALSARTAN 10-160 MG, manufactured by Alembic Pharmaceuticals Inc., is $0.3592 per EA (NDC 62332020690), effective Aug 19, 2026.

How has the price of AMLODIPINE-VALSARTAN 10-160 MG changed over time?

Over the history we have for it, the NADAC for AMLODIPINE-VALSARTAN 10-160 MG has declined 26.0%. It has been tracked across 473 weekly CMS publications since Aug 2, 2017.

What are the highest and lowest recorded NADAC prices for AMLODIPINE-VALSARTAN 10-160 MG?

Since Aug 2, 2017, the NADAC for AMLODIPINE-VALSARTAN 10-160 MG has ranged from a low of $0.3145 (May 22, 2024) to a high of $0.6405 (Aug 11, 2021), with a median of $0.5068 per EA.

Are there cheaper alternatives to AMLODIPINE-VALSARTAN 10-160 MG?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as AMLODIPINE-VALSARTAN 10-160 MG in a comparable dosage form, but none are currently priced below it.

Who manufactures AMLODIPINE-VALSARTAN 10-160 MG?

AMLODIPINE-VALSARTAN 10-160 MG (NDC 62332020690) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.